Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Cost of Revenue (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Cost of Revenue for 1 consecutive years, with $475000.0 as the latest value for Q1 2024.

  • On a quarterly basis, Cost of Revenue changed N/A to $475000.0 in Q1 2024 year-over-year; TTM through Dec 2024 was $475000.0, a N/A change, with the full-year FY2024 number at $475000.0, changed N/A from a year prior.
  • Cost of Revenue was $475000.0 for Q1 2024 at Pyxis Oncology.
  • In the past five years, Cost of Revenue ranged from a high of $475000.0 in Q1 2024 to a low of $475000.0 in Q1 2024.